Artal Group’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-276,077	Closed	-$8.73M	–	103
2023 Q3	$8.73M	Hold	276,077	–	–	0.37%	42
2023 Q2	$11.3M	Hold	276,077	–	–	0.35%	44
2023 Q1	$10.3M	Buy	276,077 +1,077	+0.4%	+$40.1K	0.61%	41
2022 Q4	$9.6M	Hold	275,000	–	–	0.54%	41
2022 Q3	$15.4M	Hold	275,000	–	–	0.66%	31
2022 Q2	$14.2M	Hold	275,000	–	–	0.76%	30
2022 Q1	$20M	Hold	275,000	–	–	0.84%	29
2021 Q4	$32.5M	Hold	275,000	–	–	0.88%	26
2021 Q3	$36.9M	Buy	275,000 +25,000	+10%	+$3.35M	0.83%	27
2021 Q2	$40.5M	Hold	250,000	–	–	0.82%	21
2021 Q1	$20.1M	Hold	250,000	–	–	0.35%	56
2020 Q4	$13.6M	Buy	250,000 +60,000	+32%	+$3.26M	0.29%	73
2020 Q3	$3.78M	Sell	190,000 -49,000	-21%	-$974K	0.09%	92
2020 Q2	$5.02M	Buy	+239,000	New	+$5.02M	0.14%	90
2020 Q1	–	Sell	-199,700	Closed	-$2.93M	–	103
2019 Q4	$2.93M	Buy	+199,700	New	+$2.93M	0.11%	75
2018 Q4	–	Sell	-90,000	Closed	-$2.58M	–	94
2018 Q3	$2.58M	Hold	90,000	–	–	0.07%	73
2018 Q2	$2.46M	Hold	90,000	–	–	0.05%	67
2018 Q1	$1.9M	Sell	90,000 -160,000	-64%	-$3.37M	0.02%	67
2017 Q4	$4.81M	Buy	250,000 +75,000	+43%	+$1.44M	0.07%	39
2017 Q3	$4.35M	Sell	175,000 -75,000	-30%	-$1.86M	0.07%	41
2017 Q2	$4M	Hold	250,000	–	–	0.07%	49
2017 Q1	$3.52M	Hold	250,000	–	–	0.08%	51
2016 Q4	$3.28M	Buy	250,000 +45,000	+22%	+$590K	0.07%	39
2016 Q3	$3.49M	Sell	205,000 -20,000	-9%	-$340K	0.07%	46
2016 Q2	$4.8M	Buy	+225,000	New	+$4.8M	0.1%	29